Los Angeles-based advisors Katrina Soelter and Leighann Miko on Thursday announced the launch of their RIA technology and services co-operative Avise Financial. The virtual platform seeks to ...
SAN DIEGO, July 05, 2022 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, announced new robust, real-world evidence confirming AVISE® testing enables ...
Because the AVISE Lupus Test can diagnose lupus earlier and in less severe cases than standard diagnostic laboratory tests (SDLTs), a new study finds it also results in significant savings in ...
Peloton cofounder, Graham Stanton, is shifting his focus from fitness nuts to financial wonks. Today Stanton and cofounder Edgar Thomas revealed their new accounting and bookkeeping company, Avise.
What is the AVISE® CTD? AVISE® CTD is a blood test that can help doctors diagnose lupus and other autoimmune diseases — like rheumatoid arthritis, Sjögren's syndrome, or scleroderma. The test may be ...
SAN DIEGO, May 11, 2022 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, announced today that Medicare Administrative Contractor (MAC) Noridian has ...
Exagen Inc. has reached a major milestone by completing its 1,000,000th AVISE CTD test, a diagnostic tool for autoimmune and connective tissue diseases. This achievement highlights the company’s ...
The milestone demonstrates AVISE CTD’s value and adoption within the rheumatologic community, clearly demonstrating superior laboratory testing for improved patient care CARLSBAD, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results